Scientists are working on what would be a profoundly useful new tool in early cancer detection, if successful. Johnson & Johnson announced a partnership with Massachusetts General Hospital to develop a blood test that could pinpoint a single cancer cell amongst billions of healthy ones: a life-changing needle in a massive haystack.
The news should be greeted with enthusiasm, but also caution, says Len Licthenfeld, deputy chief medical officer at the American Cancer Society.
Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you. We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll help us unlock a matching gift of $67,000!